Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024

India s largest pharmaceutical company, Piramal Pharma Limited, has announced its financial results for the second quarter (Q2 and half year (H1) ending 30th September 2023, which includes a 7% increase in revenue from Operation and 15% YoY.

Source: prnewswire.com
Published on 2023-10-28